| 3GKW: reference: Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation., Talavera A, Friemann R, Gomez-Puerta S, Martinez-Fleites C, Garrido G, Rabasa A, Lopez-Requena A, Pupo A, Johansen RF, Sanchez O, Krengel U, Moreno E, Cancer Res. 2009 Jul 15;69(14):5851-9. Epub 2009 Jul 7. PMID: 19584289 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).